Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
3
×
life sciences
national blog main
national top stories
roche
san francisco blog main
san francisco top stories
3
×
amgen
cancer
deals
venture capital
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
avapritinib
axitinib
bellus health
biotech ipos
blueprint medicines
bolt biotherapeutics
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer drugs
cell therapy
What
drug
3
×
cancer
medicines
advantages
approval
bar
bio
blueprint
brings
candidate
currently
despite
expect
family
fda
gamble
hardest
hit
hottest
hunters
ipo
market
marketing
medco’s
mover
muscle
new
pact
patients
payers
physicians
plan
pricing
proteins
ras
reels
regulatory
research
ret
review
Language
unset
3
×
Current search:
drug
×
unset
×
" san francisco top stories "
×
investing
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone